Skip to main content
. Author manuscript; available in PMC: 2010 Oct 1.
Published in final edited form as: Cancer Res. 2009 Sep 22;69(19):7793–7802. doi: 10.1158/0008-5472.CAN-08-3810

Table 1.

High-frequency deviations and minimally overlapping regions (MOR) in CR tumors. Losses (A) and gains (B) are listed separately. High-frequency is defined as observed with an adjusted frequency of ≥30%. The start position, size, and any constituent MORs observed at higher frequency than the larger deviation are given for each deviation. Mbp positions are rounded to nearest 0.1 Mbp. MORs observed at ≥50% are in bold. The start site and size of CR-associated alterations are given.

A. Losses B. Gains
Deviation
MOR
CR-associated
Deviation
MOR
CR-associated
Band Start
(Mbp)
Size
(Mbp)
(%) Start
(Mbp)
Size
(Mbp)
Start
(Mbp)
Size
(Mbp)
Band Start
(Mbp)
Size
(Mbp)
(%) Start
(Mbp)
Size
(Mbp)
Start
(Mbp)
Size
(Mbp)
1p36.23-p35.1 7.2 25.2 36 16.3 3.5 7.2 25.2 1p12-q43 120.0 117.7 65 147.9 2.8 153.6 84.3
43 26.7 2.5 52 155.2 0.7
1p33-p32.3 48.4 6.8 49 157.6 6.9
2q37.3 238.6 3.7 238.6 3.7 55 200.3 1.9
3p21.31 46.3 1.8 31 46.3 0.6 46.3 1.8 45 209.4 3.0
4p16.3-p16.1 0.1 10.6 38 2.7 0.3 0.1 4.4 1q41–43 215.6 22.1 33 220.4 7.6
5.1 5.6 2p25.1 9.6 1.8 33 9.5 1.2
4q33-q34.3 171.7 9.9 35 175.5 3.5 171.7 9.9 5q31.3 140.1 0.8
4q34.3-q35.2 182.2 8.2 37 184.3 0.9 182.2 5.2 7p22.3-q36.3 0.1 158.5 47 5.5 0.5 6.4 16.4
38 188.0 2.4 45 26.8 2.5 27.7 44.2
5q11.2-q13.2 55.1 15.9 42 55.3 7.5 47 62.0 4.0 75.3 23.6
40 67.8 2.4 55 72.6 2.6 105.6 42.1
5q14.2-q22.2 81.7 31.0 39 96.0 13.7 55 78.9 1.3
5q23.1-q23.2 115.4 11.8 35 117.6 7.3 53 99.1 3.1
5q34-q35.2 160.7 15.6 37 165.0 6.1 171.3 5.0 44 121.3 5.4
6p25.3-p22.3 0.2 21.5 39 12.3 1.2 5.8 9.1 46 128.7 0.8
6q13-q22.31 75.2 43.7 43 88.7 5.2 48 136.2 0.4
36 103.9 9.8 50 148.2 5.2
8p23.3-p11.21 0.3 40.3 67 1.5 1.7 8p12-q24.3 36.5 109.6 64 43.3 6.0 42.9 103.2
66 4.6 1.6 69 57.2 8.2
74 19.8 3.5 81 79.3 0.5
71 25.5 1.8 82 93.3 6.0
10p15.3-q26.3 0.2 135.1 39 0.2 0.1 0.2 42.6 79 102.3 2.5
47 9.0 3.3 50.4 25.7 78 115.1 6.5
44 32.4 2.8 79.1 15.7 73 131.1 2.4
42 43.0 1.0 95.9 39.4 9q33.2 122.4 1.1
52 72.0 2.4 9q33.2-q33.3 124.3 3.8 33 124.6 1.1
86 89.4 1.2 9q34.11 129.5 0.8
68 98.2 3.7 11q12.1-q24.1 59.4 63.0 42 65.8 1.2 77.5 39.5
68 103.4 0.4 41 73.5 1.3
79 105.9 5.0 39 83.8 18.4
68 121.7 6.9 40 105.3 4.2
11p15.4 4.2 0.3 33 117.8 0.4
13q11-q34 18.4 95.0 50 18.4 4.4 18.4 9.7 11q23.3-q24.1 119.0 3.4
45 27.0 1.1 97.2 16.2 11q24.1-q24.2 123.1 2.7 32 123.1 2.3 123.1 2.3
80 40.6 0.8 12q24.31-q24.32 119.8 4.8 33 119.8 2.8
85 44.6 3.1 16p13.3 0.9 2.4
64 52.1 0.1 16p12.1-p11.1 27.6 6.9 35 29.7 4.8
63 72.4 2.6 18p11.32 0.2 2.0
59 101.3 2.8 Xp22.31-p22.12 7.5 11.8
15q24.3-q25.1 75.1 1.9 71.4 13.9 Xp11.22-q13.1 51.5 16.5 50 65.1 2.8 65.1 2.8
15q25.1-q26.3 78.7 21.3 40 85.4 7.4 86.5 4.1
96.6 3.4
16q11.2-q24.3 45.3 43.3 57 49.4 5.3 55.0 4.3
47 63.6 0.2 65.0 2.2
82 80.7 1.6 82.4 6.2
17p13.3-p11.2 0.1 19.5 51 0.1 0.5 0.1 15.2
61 7.6 0.3 15.4 4.2
17q24.2-q25.3 64.6 8.9 41 66.1 2.6 64.6 8.9
17q25.3 74.4 1.6 73.8 2.1
18q12.1-q23 28.2 47.9 75.4 0.7
19p12-q13.11 19.9 20.3 40 34.3 2.2
19q13.2-q13.31 46.1 2.5 36 47.4 0.6 46.1 2.5
21q22.2-q22.3 38.7 4.5 38 38.7 3.0
22q11.1-q13.33 16.2 33.2 65 24.6 1.6 16.2 8.2
46 43.4 6.0 26.7 23.2

Abbreviations: “Chr.” = chromosome, “Min”. = the minimum observed frequency for the larger deviation, and “MOR (%)”= the peak frequency that defines the MOR.